Evidence map›Paper›PMID 36284570›Full record

ReviewThe Pan African medical journal2022

Post COVID-19 rhinocerebral mucormycosis: a case report and literature review.

Amel El Korbi, Salma Bhar, Emna Bergaoui, Khaled Harrathi, Jamel Koubaa

Open access · goldAbstract readReviewCase Reports
In one paragraph

Review in The Pan African medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Amel El KorbiDepartment of Ear, Nose, and Throat (ENT), Fattouma Bourguiba Teaching Hospital, Monastir, Tunisia.
Salma BharDepartment of Ear, Nose, and Throat (ENT), Fattouma Bourguiba Teaching Hospital, Monastir, Tunisia.
Emna BergaouiDepartment of Ear, Nose, and Throat (ENT), Fattouma Bourguiba Teaching Hospital, Monastir, Tunisia.
Khaled HarrathiDepartment of Ear, Nose, and Throat (ENT), Fattouma Bourguiba Teaching Hospital, Monastir, Tunisia.
Jamel KoubaaDepartment of Ear, Nose, and Throat (ENT), Fattouma Bourguiba Teaching Hospital, Monastir, Tunisia.
University of Monastir · TNHospital Fatuma Bourguiba Monastir · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pandemic of coronavirus disease 2019 (COVID-19) still remains on an upsurge trend. The second and the waves of this disease have led to panic in many countries, and some parts of the world suffering from the fourth wave. In the midst of this pandemic, COVID-19 patients are acquiring secondary infections such as mucormycosis also known as "black fungus disease". Mucormycosis is a serious, but rare opportunistic fungal infection that spreads rapidly, and hence prompt diagnosis and treatment are necessary to avoid mortality and morbidity rate. We report in this paper, a case of a diabetic patient who presented with bilateral nasal obstruction, anosmia, and frontal headache diagnosed with rhinocerebral mucormycosis developing after COVID-19 infection with a favorable outcome after a medico-surgical treatment. Through this case, we aim to aware patricians of this possible association and the importance of early diagnosis to optimize treatment outcomes.

Indexed as

COVID-19Diabetes MellitusMucormycosisOpportunistic InfectionsHumansTreatment Outcomecase reportCOVID-19diabetesmucormycosisrhinocerebral

Identifiers

PMID36284570
PMCPMC9547023
OpenAlexW4285413725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.